A Critical Appraisal of the Evidence Supporting Consumer Motivations for Alternative Proteins. [PDF]
Tso R, Lim AJ, Forde CG.
europepmc +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Comprehensive Review of Alternative Proteins in Pet Food: Research Publications, Patents, and Product Trends in Plant, Aquatic, Insect, and Cell-Based Sources. [PDF]
Klinmalai P +11 more
europepmc +1 more source
Alternative proteins are functional regulators in cell reprogramming by PKA activation. [PDF]
Cardon T +8 more
europepmc +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
Alternatives to animal-source foods for sustainable, equitable, and healthy food systems
Francesco Branca
doaj +1 more source
A study on safety evaluation system of cultured foods among alternative proteins. [PDF]
Heo S, Lee G, Jeong DW.
europepmc +1 more source
Physicochemical Properties and Consumer Acceptance of Bread Enriched with Alternative Proteins. [PDF]
García-Segovia P +2 more
europepmc +1 more source
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source

